Markets
KURA

Kura Oncology Inc. Q4 Loss Increases

March 05, 2026 — 06:45 am EST

Written by RTTNews.com for RTTNews->

(RTTNews) - Kura Oncology Inc. (KURA) reported Loss for its fourth quarter of -$80.999 million

The company's bottom line came in at -$80.999 million, or -$0.92 per share. This compares with -$19.217 million, or -$0.22 per share, last year.

The company's revenue for the period fell 67.8% to $17.336 million from $53.883 million last year.

Kura Oncology Inc. earnings at a glance (GAAP) :

-Earnings: -$80.999 Mln. vs. -$19.217 Mln. last year. -EPS: -$0.92 vs. -$0.22 last year. -Revenue: $17.336 Mln vs. $53.883 Mln last year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

KURA

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.